(Reuters) - Celsion Corp said a late-stage study of its experimental liver cancer treatment ThermoDox did not meet the main goal of increasing patients' survival without their cancer worsening. The study, named HEAT, was designed to show a 33 ...
Source: http://health.yahoo.net/news/s/nm/celsion-s-liver-cancer-therapy-fails-to-meet-late-stage-trial-goal
as explained here resource source here i found it
No comments:
Post a Comment
Note: only a member of this blog may post a comment.